BeStock  
Stocks › Medical Devices › IART

Integra Lifesciences IART

US equityMarket cap rank #3137Medical DevicesBrain-Computer Interface
$13.25 −$0.30 (-2.21%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $12.99 -1.96%
Open$13.38
Prev close$13.55
Day range$13.16 – $13.79
Volume828.6K
Market cap$1.03B
P/E (TTM)77.9
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$411.18M+2.3% YoY
Operating profit$18.90M+60.7% YoY
Net profit$14.85M+374.8% YoY
Diluted EPS$0.19+371.4% YoY
Free cash flow$85.73M+232.9% YoY
Operating cash flow$95.98M

Revenue, last 8 quarters

$442.6MDec '24$382.7MMar '25$415.6MJun '25$402.1MSep '25$434.9MDec '25$391.9MMar '26$418.8MJun '26$411.2MSep '26

Net profit, last 8 quarters

$19.4MDec '24$-25.3MMar '25$-484.1MJun '25$-5.4MSep '25$-1.7MDec '25$-4.6MMar '26$4.5MJun '26$14.9MSep '26

Diluted EPS by quarter

0.25Dec '24-0.33Mar '25-6.31Jun '25-0.07Sep '25-0.02Dec '25-0.06Mar '260.06Jun '260.19Sep '26

Free cash flow by quarter

$11.2MDec '24$-40.2MMar '25$-11.2MJun '25$25.8MSep '25$-19.6MDec '25$-5.0MMar '26$10.5MJun '26$85.7MSep '26

Annual revenue

$1.4BFY20$1.5BFY21$1.6BFY22$1.5BFY23$1.6BFY24$1.6BFY25

Profitability & balance sheet

Gross margin52.4%
Operating margin4.4%
Net margin0.8%
Return on equity0.7%
Return on assets0.4%
Return on invested capital2.1%
Current ratio3.62
Liabilities / assets69.6%
Cash & investments$311.93M
Total debt$161.09M
Net cash (debt)$150.84M
Free cash flow / sales4.3%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Specialty Surgery$304.12M 74.0%
  • Tissue Reconstruction$107.06M 26.0%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $411.18M $418.76M $391.92M $1.64B $434.93M
Total Operating Revenue $411.18M $418.76M $391.92M $1.64B $434.93M
Cost of Revenue $201.32M $199.02M $174.94M $803.63M $214.06M
Gross Profit $209.87M $219.74M $216.98M $831.62M $220.87M
Operating Expense $190.97M $200.46M $205.51M $813.63M $197.83M
Selling and Admin Expenses $165.31M $172.44M $178.24M $699.70M $169.27M
Research & Development $21.90M $24.25M $23.50M $98.97M $24.79M
Depreciation & Amortization & Depletion $3.76M $3.77M $3.78M $14.95M $3.77M
-Depreciation & Amortization $3.76M $3.77M $3.78M $14.95M $3.77M
Operating Profit $18.90M $19.29M $11.47M $18.00M $23.04M
Net Non-Operating Interest Income (Expense) -$17.96M -$18.73M -$18.36M -$67.78M -$19.31M
Non-Operating Interest Income $5.00M $4.27M $4.11M $18.47M $4.36M
Non-Operating Interest Expense $22.96M $22.99M $22.47M $86.26M $23.67M
Other Income (Expense) $14.72M $4.19M $4.48M -$513.72M $581,000.00
Special Income (Charges) $0.00 $0.00 – -$511.37M $0.00
-Less:Impairment of Capital Assets $0.00 $0.00 – $511.37M $0.00
Other Non-Operating Income (Expenses) $14.72M $4.19M $4.48M -$2.35M $581,000.00
Pretax Profit $15.66M $4.74M -$2.41M -$563.50M $4.31M
Tax $812,000.00 $262,000.00 $2.21M -$47.03M $6.01M
Net Profit $14.85M $4.48M -$4.62M -$516.47M -$1.70M
Profit from Continuing Operations $14.85M $4.48M -$4.62M -$516.47M -$1.70M
Net Income to Parent Company $14.85M $4.48M -$4.62M -$516.47M -$1.70M
Net Income to Common Stockholders $14.85M $4.48M -$4.62M -$516.47M -$1.70M
Basic EPS $0.19 $0.06 -$0.06 -$6.74 -$0.02
Diluted EPS $0.19 $0.06 -$0.06 -$6.74 -$0.02

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $3.51B $3.56B $3.58B $3.60B $3.60B
Total Current Assets $1.19B $1.19B $1.17B $1.16B $1.16B
Cash and Cash Equivalents & Short-Term Investments $311.93M $274.08M $265.50M $263.74M $263.74M
-Cash and Cash Equivalents $252.26M $214.42M $236.81M $235.05M $235.05M
-Short Term Investments $59.67M $59.67M $28.69M $28.69M $28.69M
Prepaid Assets $117.62M $104.34M $97.71M $96.09M $96.09M
Other Current Assets $1.07B $53.86M $49.35M $28.13M $28.13M
Total Non-Current Assets $2.32B $2.37B $2.41B $2.44B $2.44B
-Goodwill $607.83M $611.15M $613.25M $615.16M $615.16M
Non-Current Deferred Assets $66.71M $70.44M $68.08M $69.85M $69.85M
Other Non-Current Assets $2.25B $31.59M $34.96M $37.88M $37.88M
Total Liabilities $2.44B $2.52B $2.54B $2.56B $2.56B
Total Current Liabilities $329.00M $330.88M $346.85M $455.98M $455.98M
-Accounts Payable $66.42M $82.64M $87.95M $95.73M $95.73M
Current Accrued Expenses $101.84M $107.62M $133.32M $130.49M $130.49M
-Current Capital Lease Obligation $14.59M $13.92M $13.93M $14.02M $14.02M
Total Non-Current Liabilities $2.11B $2.19B $2.19B $2.10B $2.10B
Long Term Debt and Capital Lease Obligation $161.09M $1.99B $1.99B $1.89B $1.89B
-Long Term Capital Lease Obligation $161.09M $162.66M $160.12M $163.06M $163.06M
Other Non-Current Liabilities $2.11B $194.40M $195.56M $204.28M $204.28M
Total Equity $1.07B $1.04B $1.04B $1.04B $1.04B
Stockholders' Equity $2.47B $1.04B $1.04B $1.04B $1.04B
Capital Stock $0.00 $921,000.00 $922,000.00 $923,000.00 $923,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.35B $1.35B $1.34B $1.34B $1.34B
Retained Earnings $438.16M $423.31M $418.82M $423.44M $423.44M
Less: Treasury Stock -$684.09M -$686.92M -$687.12M -$689.21M -$689.21M
Receivables – $267.19M $264.41M $278.85M $278.85M
-Accounts Receivable – $267.19M $264.41M $278.85M $278.85M
Inventory – $492.01M $495.04M $492.74M $492.74M
Net PPE – $583.29M $584.08M $584.90M $584.90M
-Gross PPE – $583.29M $584.08M $1.03B $1.03B
Goodwill and Other Intangible Assets – $1.69B $1.72B $1.75B $1.75B
-Other Intangible Assets – $1.08B $1.11B $1.13B $1.13B
Payables – $85.87M $91.18M $99.38M $99.38M
-Total Tax Payable – $3.24M $3.24M $3.65M $3.65M
Short-Term Debt and Capital Lease Obligation – $57.51M $52.68M $140.57M $140.57M
-Current Debt – $43.59M $38.75M $126.55M $126.55M
Current Deferred Liabilities – $11.70M $11.62M $11.46M $11.46M
-Long Term Debt – $1.83B $1.83B $1.73B $1.73B
Non-Current Deferred Liabilities – $3.47M $6.14M $5.66M $5.66M
-Common Stock – $921,000.00 $922,000.00 $923,000.00 $923,000.00
Gains/Losses Not Affecting Retained Earnings – -$40.20M -$30.94M -$30.08M -$30.08M
-Accumulated Depreciation – – – -$443.95M -$443.95M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $95.98M $22.80M $9.80M $50.38M $11.82M
Net cash flow from continuing operations $95.98M $22.80M $9.80M $50.38M $11.82M
Net Income from Continuing Operations $14.85M $4.48M -$4.62M -$516.47M -$1.70M
Gain/Loss from Continuing Operations $1.48M $643,000.00 $90,000.00 $490,000.00 $0.00
Depreciation & Depletion & Amortization $39.06M $38.14M $38.43M $151.83M $38.43M
Deferred Tax $703,000.00 -$4.33M $1.33M -$66.26M -$10.95M
Other Non-Cash Items -$206,000.00 $4.16M $32,000.00 -$15.41M -$4.45M
Change in Working Capital $37.19M -$26.13M -$30.62M -$33.74M -$15.35M
-Change in Receivables $17.96M -$3.04M $13.65M -$485,000.00 -$16.45M
-Change in Inventory $24.13M $474,000.00 -$4.33M -$46.76M -$3.34M
-Change in Prepaid Assets -$1.33M -$7.44M -$21.88M -$2.80M $2.19M
-Change in Payables and Accrued Expense -$4.15M -$15.20M -$19.19M $26.72M $23.02M
-Change in Other Current Assets $1.83M -$996,000.00 $1.39M $3.34M $8,000.00
-Change in Other Current Liabilities -$1.03M $836,000.00 $369,000.00 -$17.16M -$21.46M
-Change In Other Working Capital -$228,000.00 -$762,000.00 -$630,000.00 $3.40M $685,000.00
Net cash flow from investing -$10.25M -$43.28M -$14.85M -$108.06M -$34.91M
Net Cash Flow from Continuing Investing Activities -$10.25M -$43.28M -$14.85M -$108.06M -$34.91M
Net PPE Purchase and Sale -$10.25M -$12.31M -$14.85M -$81.44M -$17.21M
Net Investment Purchase and Sale $0.00 -$30.98M $0.00 -$12.43M -$3.49M
Financing Cash Flow -$46.29M -$818,000.00 $8.30M $28.34M $24.34M
Net Cash Flow from Continuing Financing Activities -$46.29M -$818,000.00 $8.30M $28.34M $24.34M
Net Issuance Payments Of Debt -$46.09M $6.51M $8.91M $50.81M $24.61M
Net Common Stock Issuance $0.00 – – -$221,000.00 $0.00
Proceeds from Stock Option Exercised $0.00 $0.00 $760,000.00 $957,000.00 $0.00
Net Other Financing Charges -$200,000.00 -$7.33M -$1.38M -$23.21M -$271,000.00
Ending Cash Balance $252.26M $214.42M $236.81M $235.05M $235.05M
Net Change in Cash $39.44M -$21.30M $3.25M -$29.34M $1.25M
Beginning Cash Balance $214.42M $236.81M $235.05M $246.38M $232.19M
Effect of Exchange Rate Changes -$1.60M -$1.10M -$1.49M $18.02M $1.61M
Free Cash Flow $85.73M $10.50M -$5.05M -$45.25M -$19.60M
Net Intangibles Purchase and Sale – – – -$14.20M –
Net Business Purchase and Sale – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on IART.

Sign in to join the discussion.

Scroll to Top